| Trial registration number
|
IRCT20111224008507N5 |
Full text link
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/54402
|
First author
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Dr. Majid Saeidi
|
Contact
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
msaidi@mazums.ac.ir
|
Registration date
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2021-02-22
|
Recruitment status
Last imported at : Aug. 25, 2021, 6:48 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Patients with positive coronavirus rapid test or RT-PCR
Age>5 years
Weight >15 kg
No treatment with antiviral drugs before and during the study
Informed consent for participation
|
Exclusion criteria
Last imported at : March 5, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Underlying liver and kidney disease
Patients with acquired immunodeficiency
Pregnancy and lactation
|
Number of arms
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Mazandaran University of Medical Sciences
|
Inclusion age min
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
5
|
Inclusion age max
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
100
|
Countries
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Moderate/severe/critical disease at enrollment
|
Severity scale
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
5: Moderate/severe/critical disease at enrollment
|
Total sample size
Last imported at : March 5, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
1000
|
primary outcome
Last imported at : March 5, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Reduction in persistent cough
Negative RT-PCR result
The main complaints recovery time
Mortality
Drug side effect (Wheezing, itching, skin rash, edema, and hypotension)
Reduction in tachypnea
Oxigen saturation >94%
|
Notes
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : Feb. 23, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 3
|
Arms
Last imported at : March 5, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 693, "treatment_name": "Ivermectin", "treatment_type": "Antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|